Peptide library › Bone health
Palopegteriparatide
Also known as Yorvipath, TransCon PTH
Daily long-acting parathyroid hormone replacement for adults with hypoparathyroidism.
What people use it for
- Hypoparathyroidism in adults
What Palopegteriparatide does in the body
A prodrug that slowly releases the active part of parathyroid hormone, PTH(1-34), giving steady levels through the day. This keeps blood calcium normal without large doses of calcium and vitamin D.
Strength of evidence
Strong: the Phase 3 PaTHway trial kept calcium normal in most people without standard supplements.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- High or low calcium while the dose is adjusted
- Injection-site reactions
- Headache
- Bone cancer (osteosarcoma) warning based on rat studies of PTH drugs
Who should avoid it or take extra care
- Higher risk of osteosarcoma, such as Paget's disease or previous radiation to bone
- Children and young adults with open growth plates
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2024, after earlier approval in Europe. Prescription only.
How it's taken
Route: Injection under the skin, once daily
How long it lasts (half-life): About 60 hours for the released hormone
Storage
Refrigerated before first use; then follow the pen instructions.
Keep track of Palopegteriparatide privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Palopegteriparatide in Fiala How to installMore in Bone health
- TeriparatideBone-building form of parathyroid hormone approved for severe osteoporosis.
- AbaloparatideDaily bone-building injection for osteoporosis in people at high risk of fractures.
- Calcitonin (salmon)Hormone from salmon used for Paget's disease of bone, high calcium and, less often now, osteoporosis.
- Parathyroid hormoneFull-length lab-made parathyroid hormone for low calcium caused by hypoparathyroidism; supply has been limited.
- VosoritideDaily injection that helps children with achondroplasia, the most common form of dwarfism, grow faster.
- EtelcalcetideInjection given at dialysis to lower overactive parathyroid hormone in people with kidney failure.